• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素类似物用于体外受精治疗后的卵泡囊肿和黄体囊肿。

Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization.

作者信息

Ben-Rafael Z, Bider D, Menashe Y, Maymon R, Zolti M, Mashiach S

机构信息

Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

出版信息

Fertil Steril. 1990 Jun;53(6):1091-4. doi: 10.1016/s0015-0282(16)53592-4.

DOI:10.1016/s0015-0282(16)53592-4
PMID:2140993
Abstract

Ovarian cysts are a common complication of GnRH-a administration. We followed 98 patients who were suppressed with GnRH-a before ovarian stimulation with hMG for IVF treatment. Approximately 20% of the patients receiving GnRH-a during the follicular or luteal phase had developed ovarian cysts. However, the number of cysts per patient was significantly higher in the follicular phase compared with luteal phase. Systematic aspiration of those cysts under local anesthesia permitted the start of ovarian stimulation with hMG as scheduled on day 16 after GnRH-a administration. Follicular fluid content of the cysts revealed similar levels of steroids to those in normal follicles. These cysts contained few cells and no egg. In vitro fertilization treatment was more successful in patients whose cysts were aspirated during the luteal phase than in those with cysts during the follicular phase. We concluded that luteal phase cysts are more benign than follicular phase cysts, and it is possible that they represent an enlargement of pre-existing corpora lutea.

摘要

卵巢囊肿是 GnRH-a 给药后的常见并发症。我们对 98 例在使用 hMG 进行卵巢刺激以进行 IVF 治疗前接受 GnRH-a 抑制的患者进行了随访。在卵泡期或黄体期接受 GnRH-a 的患者中,约 20% 出现了卵巢囊肿。然而,与黄体期相比,卵泡期每位患者的囊肿数量明显更高。在局部麻醉下对这些囊肿进行系统抽吸后,可在 GnRH-a 给药后第 16 天按计划开始用 hMG 进行卵巢刺激。囊肿的卵泡液成分显示,其类固醇水平与正常卵泡相似。这些囊肿细胞很少,没有卵子。黄体期囊肿抽吸患者的体外受精治疗比卵泡期囊肿患者更成功。我们得出结论,黄体期囊肿比卵泡期囊肿更良性,它们可能是已存在的黄体的增大。

相似文献

1
Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization.促性腺激素释放激素类似物用于体外受精治疗后的卵泡囊肿和黄体囊肿。
Fertil Steril. 1990 Jun;53(6):1091-4. doi: 10.1016/s0015-0282(16)53592-4.
2
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
3
Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
Fertil Steril. 1991 Jun;55(6):1157-64. doi: 10.1016/s0015-0282(16)54368-4.
4
Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.在体外受精的卵巢刺激过程中,促性腺激素释放激素激动剂提前停用后的卵泡期和黄体期特征。
Hum Reprod. 2000 Jan;15(1):43-9. doi: 10.1093/humrep/15.1.43.
5
Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.黄体期每日小剂量 hCG 刺激联合 GnRHa 触发无外源性孕激素的 IVF 周期:概念验证试验。
Hum Reprod. 2015 Oct;30(10):2387-95. doi: 10.1093/humrep/dev184. Epub 2015 Jul 23.
6
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.在多囊卵泡发育病例中,低剂量人绒毛膜促性腺激素用于GnRH激动剂触发排卵后黄体支持的安全性和有效性。
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22.
7
A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.在体外受精中,促性腺激素释放激素激动剂黄体期起始与卵泡期同期起始的前瞻性随机比较。
Fertil Steril. 1992 Oct;58(4):744-9. doi: 10.1016/s0015-0282(16)55322-9.
8
The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist.长效促性腺激素释放激素激动剂在卵泡早期和黄体中期给药的比较。
Fertil Steril. 1990 Aug;54(2):233-7. doi: 10.1016/s0015-0282(16)53695-4.
9
Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.在使用促性腺激素释放激素类似物和尿促性素刺激的体外受精中,黄体期注射人绒毛膜促性腺激素后的妊娠率及卵巢过度刺激情况
Fertil Steril. 1990 Jan;53(1):92-6. doi: 10.1016/s0015-0282(16)53222-1.
10
Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.对人绒毛膜促性腺激素的促黄体生成素反应不能预测促性腺激素释放激素激动剂抑制/人绝经后促性腺激素刺激的体外受精(IVF)周期的结局。
J Assist Reprod Genet. 1992 Jun;9(3):244-7. doi: 10.1007/BF01203821.

引用本文的文献

1
Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article.体外受精治疗后女性患卵巢癌风险的有力证据:一篇综述文章。
Iran J Public Health. 2019 Dec;48(12):2124-2132.
2
Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval.自然周期辅助生殖中第二卵泡波现象的评估:通过黄体期取卵为卵巢低反应者提供的关键选择。
Medicina (Kaunas). 2019 Mar 14;55(3):68. doi: 10.3390/medicina55030068.
3
Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles.
体外受精中卵泡期降调节期间的卵巢活动与高龄产妇及后续周期的高复发率相关。
J Assist Reprod Genet. 1995 May;12(5):301-4. doi: 10.1007/BF02213708.